Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Achilles Therapeutics PLC ADR
ACHLCurrent price
1.17 USD
+0.01 USD (+0.86%)
Last closed
1.16 USD
Company
www.achillestx.com
ISIN
US00449L1026
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
42 156 812 USD
Yield for 12 month
+32.83 %
1Y
3Y
5Y
10Y
15Y
ACHL
Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom. Address: 245 Hammersmith Road, London, United Kingdom, W6 8PW
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-4 731 267 USD
Last Year
-3 687 722 USD
Current Quarter
–
Last Quarter
-1 178 319 USD
Key Figures ACHL
1 year
3 years
5 years
10 years
EBITDA
-65 899 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.82 %
PEG Ratio
–
Return On Equity TTM
-44.22 %
Wall Street Target Price
6.00 USD
Revenue TTM
–
Book Value
3.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.66 USD
Diluted Eps TTM
-1.66 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ACHL
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ACHL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ACHL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
1.66
Price Book MRQ
0.39
Financials ACHL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ACHL
For 52 weeks
0.63 USD
1.76 USD
50 Day MA
1.03 USD
Shares Short Prior Month
215 692
200 Day MA
0.93 USD
Short Ratio
1.69
Shares Short
136 659
Short Percent
0.63 %
BeatStart